JP2013529679A5 - - Google Patents

Download PDF

Info

Publication number
JP2013529679A5
JP2013529679A5 JP2013517669A JP2013517669A JP2013529679A5 JP 2013529679 A5 JP2013529679 A5 JP 2013529679A5 JP 2013517669 A JP2013517669 A JP 2013517669A JP 2013517669 A JP2013517669 A JP 2013517669A JP 2013529679 A5 JP2013529679 A5 JP 2013529679A5
Authority
JP
Japan
Prior art keywords
xylitol
injectable pharmaceutical
agent
pharmaceutical formulation
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013517669A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013529679A (ja
Filing date
Publication date
Priority claimed from IL206739A external-priority patent/IL206739A/en
Application filed filed Critical
Publication of JP2013529679A publication Critical patent/JP2013529679A/ja
Publication of JP2013529679A5 publication Critical patent/JP2013529679A5/ja
Pending legal-status Critical Current

Links

JP2013517669A 2010-06-30 2011-06-15 関節の処置のための注射用医薬組成物 Pending JP2013529679A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL206739A IL206739A (en) 2010-06-30 2010-06-30 An injectable drug containing silitol as an active substance
IL206739 2010-06-30
PCT/IL2011/000495 WO2012001679A1 (en) 2010-06-30 2011-06-15 Injectable pharmaceutical compositions for the treatment of joints

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016063344A Division JP6166811B2 (ja) 2010-06-30 2016-03-28 関節の処置のための注射用医薬組成物

Publications (2)

Publication Number Publication Date
JP2013529679A JP2013529679A (ja) 2013-07-22
JP2013529679A5 true JP2013529679A5 (enExample) 2014-07-17

Family

ID=43569968

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2013517669A Pending JP2013529679A (ja) 2010-06-30 2011-06-15 関節の処置のための注射用医薬組成物
JP2016063344A Expired - Fee Related JP6166811B2 (ja) 2010-06-30 2016-03-28 関節の処置のための注射用医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016063344A Expired - Fee Related JP6166811B2 (ja) 2010-06-30 2016-03-28 関節の処置のための注射用医薬組成物

Country Status (9)

Country Link
US (2) US9913808B2 (enExample)
EP (1) EP2588080B1 (enExample)
JP (2) JP2013529679A (enExample)
KR (1) KR101842295B1 (enExample)
CA (1) CA2803257C (enExample)
ES (1) ES2679279T3 (enExample)
HU (1) HUE039724T2 (enExample)
IL (1) IL206739A (enExample)
WO (1) WO2012001679A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL206739A (en) 2010-06-30 2016-06-30 David Segal An injectable drug containing silitol as an active substance
WO2017069822A2 (en) 2015-07-20 2017-04-27 The Brigham And Women's Hospital, Inc. Shear-thinning compositions as an intravascular embolic agent
WO2019038763A1 (en) 2017-08-22 2019-02-28 Moebius Medical Ltd. LIPOSOMAL FORMULATION FOR JOINT LUBRICATION
CN112218942A (zh) * 2018-06-25 2021-01-12 赛斯特姆公司 从人诱导多能干细胞制备软骨细胞颗粒的方法及其用途
WO2022168968A1 (ja) * 2021-02-05 2022-08-11 学校法人近畿大学 末梢神経障害の予防又は改善剤
CA3266614A1 (en) 2023-01-19 2024-07-25 Moebius Medical Ltd. LONG-ACTING LIPOSOMAL COMPOSITION FOR THE TREATMENT OF PAIN IN JOINT DISORDERS

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
IT1198449B (it) 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
JP2788340B2 (ja) 1989-12-21 1998-08-20 株式会社ニッショー 炎症治療剤
US5095037B1 (en) 1989-12-21 1995-12-19 Nissho Kk Combined anti-inflammatory agent
AUPM922394A0 (en) * 1994-11-03 1994-11-24 Astra Pharmaceuticals Pty Ltd Plastic syringe with overcap
PT790056E (pt) * 1995-08-07 2005-02-28 Suntory Ltd Preventivo ou remedio para doencas provocadas por anormalidades nos tecidos cartilaginosos
US6294170B1 (en) * 1997-08-08 2001-09-25 Amgen Inc. Composition and method for treating inflammatory diseases
DK1092447T3 (da) * 1999-10-14 2004-05-10 Becton Dickinson Co Nasalafgivelsesindretning indbefattende en spröjtedyse
US6716819B2 (en) * 2000-05-19 2004-04-06 University Of Iowa Research Foundation Use of xylitol to reduce ionic strength and activate endogenous antimicrobials for prevention and treatment of infections
FR2833173B1 (fr) * 2001-12-10 2004-08-27 Roquette Freres Preparation antipyretique renfermant du xylitol
KR100931784B1 (ko) * 2003-10-23 2009-12-14 오츠카 세이야쿠 가부시키가이샤 방출조절성 멸균 아리피프라졸 주사제, 그 제조방법
US20070021357A1 (en) * 2005-06-17 2007-01-25 Dynamis Therapeutics, Inc. Treatment of inflammatory conditions
US20070293587A1 (en) * 2006-05-23 2007-12-20 Haley Jeffrey T Combating sinus, throat, and blood infections with xylitol delivered in the mouth
CN101209344B (zh) * 2006-12-28 2012-07-04 赵超英 高渗液组合物在制备促进伤口愈合的药物中的应用
CN101450037A (zh) * 2007-11-28 2009-06-10 天津太平洋制药有限公司 一种木糖醇静脉注射液及其制备方法
FR2938187B1 (fr) 2008-11-07 2012-08-17 Anteis Sa Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur
CN101664384B (zh) * 2009-09-18 2011-09-14 杭州市第六人民医院 N-乙酰半胱氨酸盐木糖醇注射液及其制备方法和应用
CN101669962A (zh) * 2009-09-18 2010-03-17 杭州市第六人民医院 复合甘草酸氨基酸注射液及其制备方法和应用
IL206739A (en) 2010-06-30 2016-06-30 David Segal An injectable drug containing silitol as an active substance
WO2012143876A1 (en) 2011-04-19 2012-10-26 Anteis S.A. A sterile and injectable aqueous formulation for administration in the intra-articular space of an intra-articular joint

Similar Documents

Publication Publication Date Title
JP2013529679A5 (enExample)
JP2014505733A5 (enExample)
JP2014240439A5 (enExample)
WO2013101897A3 (en) Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid
HRP20250200T1 (hr) Farmaceutski pripravci koji sadrže meloksikam
BR112014011504A2 (pt) forma de dosagem farmacêutica oral inviolável compreendendo ingrediente farmacologicamente ativo, antagonista opioide e/ou agente aversivo, óxido de polialquileno e polímero aniônico
HRP20221294T1 (hr) Neuroaktivni steroidi, njihovi pripravci i uporabe
BR112013022788A2 (pt) "composição farmacêutica compreendendo uma dispersão sólida de 1-(4-benzidrilpiperazin-1-il)-3,3-difenilpropan-1-ona"
HRP20200567T1 (hr) Stabilni injektabilni farmaceutski pripravci koji sadrže 2-hidroksipropil-beta-ciklodekstrin i alfaksalon
JP2011521969A5 (enExample)
MX391861B (es) Composiciones de canabinoide y usos
AR068816A1 (es) Composiciones de brimonidina mejorada para el tratamiento del eritema
BR112015017246A2 (pt) formulação farmacêutica que compreende um corticosteroide insolúvel e um corticosteroide solúvel
WO2011126839A3 (en) Compositions and methods for improved retention of a pharmaceutical composition at a local administration site
BRPI0508933A (pt) composições para entrega tópica
AU2018258159A1 (en) Ultrapure tetrahydrocannabinol-11-oic acids
MX2014008283A (es) Formulacion de liberacion prolongada para reducir la frecuencia de orinar y metodos de uso de esta.
WO2015116856A3 (en) Farnesoid x receptor antagonists
WO2013022243A3 (ko) 신규한 바이페닐 유도체 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 포함하는 염증성 질환 또는 자가면역질환의 예방 또는 치료용 약학적 조성물
WO2015019304A3 (fr) Compositions à libération continue à base d'acide hyaluronique, et leurs applications thérapeutiques
RS52620B (sr) Upotreba hitosana za lečenje inflamatornih bolesti noktiju
WO2017182873A3 (en) Peptide-oligourea foldamer compounds and methods of their use
HK1222337A1 (zh) 用於施加药物活性成分或化妆品活性成分的局部组合物和载体
HK1215672A1 (zh) 用於治療炎症和癌症的吲哚類化合物
JP2016512247A5 (enExample)